Clariane SE (CHIX:CLARIP) YoY EPS Growth: 18.75% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:CLARIP Clariane SE CHIX:CLARIP
61 GF Score
Price €4.06
GF Value €2.50
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clariane SE YoY EPS Growth?

Clariane SE CHIX:CLARIP 61 YoY EPS Growth is 18.75% as of Jun. 2026. GuruFocus rates CHIX:CLARIP with a GF Score™ of 61/100 and a GF Value™ of €2.50 (Significantly Overvalued). The stock has 8 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Clariane SE's YoY EPS Growth for the quarter that ended in Jun. 2026 was 18.75%.

Clariane SE's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was €-0.13.

Clariane SE YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Clariane SE's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE YoY EPS Growth Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 133.69 -81.46 -861.73 61.10 101.67

Clariane SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,933.33 98.72 65.96 2,150.00 18.75
CHIX:CLARIP
61GF Score
Clariane SE CHIX:CLARIP
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Clariane SE's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(0.004--0.24)/ | -0.24 |
=101.67 %

Clariane SE's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.13--0.16)/ | -0.16 |
=18.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 18.75% mean?
Clariane SE (CHIX:CLARIP) has a YoY EPS Growth of 18.75% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Clariane SE and its competitors.
Is Clariane SE's YoY EPS Growth too high?
Clariane SE's current YoY EPS Growth is 18.75%. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's YoY EPS Growth compare to HCA and THC?
Clariane SE's YoY EPS Growth of 18.75% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Clariane SE and its competitors. Clariane SE's current YoY EPS Growth is 18.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.50, compared to a current price of €4.06 — trading 62.4% above its estimated fair value. The current YoY EPS Growth is 18.75%. Clariane SE's overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current YoY EPS Growth is 18.75% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.06 is trading 62.4% above its estimated GF Value™ of €2.50. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for CHIX:CLARIP:

  • YoY EPS Growth: 18.75%
  • GF Value™: €2.50 vs. price of €4.06 (62.4% above fair value)
  • GF Score™: 61/100 with 8 warning signs

No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for CHIX:CLARIP

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.06
Price
€2.50
GF Value